Pulmonary Disease Doctors in Pueblo, CO Accepting Medicare

5 Pulmonary Disease doctors found. Showing 1 - 5

Dumont F. Clark, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1925 E Orman Ave, Suite 254, Pueblo, CO 81004 Phone: 719-564-1542    Fax: 719-566-0916

Harvey W. Mcclung, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1925 E Orman Ave, Suite 254, Pueblo, CO 81004 Phone: 719-564-1542    Fax: 719-566-0916

Marcel Jabour Junqueira, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 N Grand Ave, Suite 140, Pueblo, CO 81003 Phone: 719-564-1542    Fax: 719-566-0916

Megan Christine Reichmuth, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 N Grand Ave Ste 140, Pueblo, CO 81003 Phone: 719-564-1542    Fax: 719-566-0916

Joshiah R. Gordon, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 N Grand Ave, Suite 140, Pueblo, CO 81003 Phone: 719-564-1542    Fax: 719-566-0916

News Archive

Research shows how scientists altered stem cells, triggered bone growth

Imagine you have a bone fracture or a hip replacement, and you need bone to form, but you heal slowly - a common fact of life for older people. Instead of forming bone, you could form fat. Researchers at the University of North Carolina School of Medicine may have found a way to tip the scale in favor of bone formation. They used cytochalasin D, a naturally occurring substance found in mold, as a proxy to alter gene expression in the nuclei of mesenchymal stem cells to force them to become osteoblasts (bone cells).

Nearly all groups of patients with spinal stenosis do better with surgery

Nearly all groups of patients with spinal stenosis—but not smokers—do better with surgery than with nonsurgical treatment, reports a study in the October 1 issue of Spine.

Lengthy treatment with low-dose 6-mercaptopurine inhibits resistant triple-negative breast cancer cells

The cover for issue 7 of Oncotarget features Figure 5, "SUM149-MA cells surviving a 6-MP treatment are sensitive to chemotherapeutic drugs," published in "Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine" by Singh, et al. which reported that the authors have reported that a lengthy treatment with low-dose 6-mercaptopurine, a clinically useful anti-inflammatory drug, inhibits such resistant cells.

High arsenic concentrations found in drinking water serving numerous US regions

Those living in the Southwestern states of the US are more likely to be exposed to high concentrations of arsenic in their drinking water, a new study finds.

Read more Medical News

› Verified 9 days ago